Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Medical Device Policy is a progressive step in propelling the country towards Atmanirbharta in the heavily import dependent Medical Device Sector
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma
The objective of this system is to shift the focus of measuring performance of hospitals from volume of services provided to value of healthcare services
The scheme is subject to statutory and regulatory approvals as may be necessary.
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
Subscribe To Our Newsletter & Stay Updated
